Kirchberg, Australia

Robert Kurzbauer

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2002-2004.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kirchberg, AT (2002)
  • Kirchberg, AU (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert Kurzbauer

Introduction

Robert Kurzbauer is a notable inventor based in Kirchberg, Austria. He has made significant contributions to the field of gene therapy and vaccine development. With a total of 2 patents, his work focuses on the manipulation of viruses for therapeutic purposes.

Latest Patents

Kurzbauer's latest patents include the Chicken embryo lethal (CELO) virus and the Chicken embryo lethal orphan (CELO) virus. The CELO virus obtained through in vitro manipulation of a plasmid-cloned CELO virus DNA is suitable for producing vectors for gene therapy. It also serves as a vaccine against infectious diseases in humans and animals, particularly birds.

Career Highlights

Robert Kurzbauer is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has been instrumental in advancing research in the field of infectious diseases and gene therapy.

Collaborations

Some of his notable coworkers include Matthew Cotten and Gotthold Schaffner. Their collaborative efforts contribute to the innovative research and development projects at Boehringer Ingelheim.

Conclusion

Robert Kurzbauer's contributions to the field of gene therapy and vaccine development highlight his role as a significant inventor. His innovative work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…